Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Neurologix, a US based developer of gene therapies, has named Adrian Adams as the new chairman and CEO with immediate effect.
Subscribe to our email newsletter
In his new role, Adams will be responsible for strengthening the company’s R&D operations and commercial infrastructures to support NLX-P101.
Prior to joining Neurologix, Adams worked as the president and CEO of Inspire Pharmaceuticals and was responsible for entire commercialization of prescription pharmaceutical products.
Additionally, the company has also appointed Andrew Koven as the president and chief administrative officer.